Finch Therapeutics Group, Inc. (FNCHQ)
OTCMKTS · Delayed Price · Currency is USD
7.45
0.00 (0.00%)
May 26, 2026, 4:00 PM EST
Finch Therapeutics Group Market Cap
Finch Therapeutics Group has a market cap or net worth of $11.96 million as of May 27, 2026. Its market cap has decreased by -32.27% in one year.
Market Cap
11.96M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$7.45
Market Cap Chart
Since March 19, 2021, Finch Therapeutics Group's market cap has decreased from 1.01B to 11.96M, a decrease of -98.81%. That is a compound annual growth rate of -57.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 11.96M | -44.76% |
| Dec 31, 2025 | 21.66M | 19.35% |
| Dec 31, 2024 | 18.15M | 213.02% |
| Dec 29, 2023 | 5.80M | -74.79% |
| Dec 30, 2022 | 22.99M | -95.14% |
| Dec 31, 2021 | 473.36M | -52.91% |
| Mar 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ZIVO Bioscience | 16.42M |
| Galera Therapeutics | 16.06M |
| Zeo ScientifiX | 15.40M |
| EOM Pharmaceuticals Holdings | 14.55M |
| HOOKIPA Pharma | 14.47M |
| Inhibitor Therapeutics | 13.69M |
| LianBio | 11.92M |
| Nymox Pharmaceutical | 11.39M |